Apricus Biosciences Inc (NASDAQ:APRI)

0.3043
Delayed Data
As of 2:33pm ET
 +0.0106 / +3.61%
Today’s Change
0.25
Today|||52-Week Range
3.34
-83.46%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close0.29
Today’s open0.30
Day’s range0.29 - 0.32
Volume1,331,518
Average volume (3 months)1,258,980
Market cap$6.8M
Data as of 2:33pm ET, 05/22/2018

Growth & Valuation

Earnings growth (last year)+11.51%
Earnings growth (this year)+42.42%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book1.01

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...+0.06+4.14%
ACSTAcasti Pharma Inc+0.01+1.92%
KTOVKitov Pharma Ltd-0.33-12.04%
HTBXHeat Biologics Inc+0.12+6.78%
Data as of 2:33pm ET, 05/22/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$12.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO, CFO, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts